Moderated by M. van Daalen

Prof. Dr. C. Rüegg (Director of PSI)

Opening Remarks

08.30

 Prof. Dr. R. Schibli

Chair

08.45

Dr. N. van der Meulen

TATTOOS – project plans at PSI

08.50 (20 + 5 min questions)

Prof. Michael Hofman

(Peter MacCallum Cancer Centre, Melbourne, Australia)

A new Era of Treating Prostate Cancer: Improving Outcomes with Theranostics

09.15 (20 min + 5 min questions)

Prof. Dr. Richard Baum

(CURANOSTICUM Wiesbaden-Frankfurt, Germany)

Experience and perspectives of non-standard radionuclides for theragnostic.

09.40 (20 min + 5 min questions)

Short break

10.05 min

PD Dr. C. Müller

Chair

10.15

Prof. Dr. George Thalmann

(Inselspital,Bern, Bern, Switzerland)

Theranostics in prostate cancer: the urologists view of unmet needs and hopes

10.40 (20 min + 5 min

questions)

Prof. Dr. Damian Wild

(University Hospital Basel, Basel Switzerland)

Theranostics in Neuroendocrine Neoplasia (NEN) – new Treatment Options

11.05 (20 min + 5 min questions)

Dr. Ulli Köster

(Institut Laue-Langevin, Grenoble, France)

Production of emerging radionuclides

11.30 (20 + 5 min question)s

Short break

11.55

Prof. Dr. R. Schibli

Round Table Discussion (Q&A Session)

with:

- Directorate, invited Speakers, representative of LRC, representative of CRS, invited Medical Doctors, representatives of industry

12.05 (45 min)

Break

Closing remarks

13.00